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Introduction
Pathogenic microbes (bacteria, fungi and viruses) are becoming a potential 
threat to the health of human beings and environment worldwide. Now-
adays the humanity has experienced the emergence and re-emergence of 
several infectious disease, including hepatitis C, HIV/AIDS, SARS, MERS, 
Lassa fever, Zika virus, and Ebola virus, as well as Yellow Fever, Influenza, 
and Measles virus [1]. Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) is a novel coronavirus that causes the coronavirus disease 
2019 (COVID-19). Since its first detection in December 2019, [2] it has af-
fected millions of people worldwide, carrying a mortality rate much high-
er than the common flu. These public health outbreaks driven by emerg-
ing COVID-19 infectious diseases constitute the forefront of global safety 
concerns and significant burden on global economies. While there is a 
pressing need for its effective treatment and prevention based on antivirals 
and vaccines, respectively, it is imperative to explore any other effective 
intervention strategies that may reduce the mortality and morbidity rates 
of this disease.
The coronavirus pandemic needs a two-pronged approach: (i) an interme-
diate/long-term the development of an effective vaccine, but their rapid 
development in the range of 1–2 years is very challenging. In the absence 
of an effective vaccine, it is expected that not only the current pandem-
ic will continue for several months, but other coronaoutbreaks may take 
place in the future, in the coming months or years [3]. Furthermore, un-
known viruses and/or pathogens will likely emerge again, and their patho-
genicity, spread, contagion, and mechanism of action will be inquired, and 
(ii) a short-term solution to find materials that inactivate enveloped virus-
es on contact to prepare ourselves for a new and unpredictable epidemic 
in the future.
The human body is a diverse ecosystem that harbors hundreds of trillions 
of microbes [4], that might be or become pathogenic under certain cir-
cumstances. The development of innovative materials capable of avoiding 
the transmission, spread, and entry of pathogens into the human body is 
currently in the spotlight. In that way, highly effective agents are need-
ed not only to control the increased spread capability of SARS-CoV-2, 
during the emergence of COVID-19 pandemic, that severely impact pub-
lic health, but it is also fundamentally essential to explore novel strategies 
for the construction and application of new materials against pathogen in-
fection. The synthesis of these materials is gaining momentum as methods 
are providing nontoxic and environmentally acceptable “green chemistry” 
procedures.
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*Abstract
Pathogenic microorganisms are becoming a potential threat to the health of human beings and the environment worldwide. In this present study, we 
have developed a polycotton fiber, in which by incorporation and functionalization of aggregated Ag NPs are achieved by using the pad-dry-cure meth-
od. Upon contact, this coating shows antimicrobial activity against S. aureus, E. Coli, C. albicans and SARS-CoV-2. The polycotton AgNP, inhibiting 
nearly of the virus was able to prevent cross-infections, and does not causes allergies or photoirritation, proving the safety of its use. To the best of our 
knowledge, this is the first report of an antimicrobial coating that could rapidly reduce the infective load of bacteria, fungi, and inhibit SARS--CoV-2. 
Taken together, the antimicrobial coating reported herein holds great promise to be developed for further application in healthcare settings.
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Often, the surface of a material is the mean by which the human body in-
teracts with microbes. Therefore, anti-pathogen strategies based on chem-
ical modification of the material surface have been developed. One proce-
dure is to form a layer on the surface of the material, thereby reducing the 
chance of contact between the pathogen and the surface of the material, 
reducing the number of pathogens adhering to the surface. Another strat-
egy is that killing the adhered pathogen directly by decorating the surface 
of the material with the biocide agent. 
Use of personal protective equipment is considered to be one of the most 
important strategies for being protected from transmissible pathogens, 
particularly when aerosol transmission occurs and when no effective 
treatment or prophylaxis is available for the disease provoked by these 
pathogens in question. In the case of COVID-19, for instance, the World 
Health Organization (WHO) has recently issued recommendation for 
widespread use of face masks as an important tool in the control of SARS-
CoV-2 spread [5]. Therefore, the current worldwide public health crisis of 
COVID-19 has highlighted the particularly emergent need for materials 
that inactivate enveloped viruses on contact for preventing transmission.
Inorganic biocide surfaces and materials have attracted much attention 
due to their better stability and safety as compared with organic reagents 
for preventing infections and transmission. Among inorganic agents, sil-
ver cation and metal are most widely used. However, Ag cations tend to 
react with Cl−, HS−, and SO42− in aqueous solution, forming precipitates, 
thus losing their biocide activity, which affects the practical application of 
Ag-loaded biocide agents to a certain extent. Ag and its compounds have 
been widely used since from ancient time, in 1000 BC, to prevent bacterial 
growth and wound infections, and make water potable [6]. Ag metal is a 
precious metal and is easily discolored under light and heat, but for many 
years, it was used as medical treatment as a broad-spectrum antibacterial 
compound before the discovery of antibiotics in the early 20th century [7].
Nanotechnology is capable of modifying both Ag cation and metal into 
their nano range, which dramatically changes their chemical and physical 
properties. Ag nanoparticles (AgNPs) acquire special attention due to its 
specificity and environment friendly approach with a wide application in 
industry and medicine due to its antibacterial, antifungal, larvicidal and 
anti-parasitic characters. The use of AgNPs has been greatly enhanced 
due to the development of antibiotic resistance against several pathogen-
ic bacteria, and they are employed in biomedical industry as coatings in 
dressings, in medicinal devices, in the form of nanogels in cosmetics and 
lotions, etc [6, 8, 9].
According to the literature, there are plenty of protocols focused on the 
production of hybrid/composite materials based on Ag NPs, whose archi-
tecture is driven by different synthetic methods and reaction mechanisms 
[10-15]. While the precise reasons for this unique chemistry and physics 
are unknown, the observed structures, their reproducibility, and synthetic 
control this reaction offers, there is plenty of room to find innovative pos-
sibilities for new technologies [16, 17].
Ag NPs have been proven to be most useful related to their potential  an-
timicrobial properties against lethal viruses, microbes/germs, and other 
microorganisms. These NPs are certainly the most extensively utilized ma-
terial among all. Thus, it has been used as antimicrobial agent in different 
textile industries. The noble metal NPs are considered as more specific 
and multipurpose agents with a diversity of biomedical applications con-
sidering their use in extremely sensitive investigative assays, radiotherapy 
enhancement, gene delivery, thermal ablation, and drug delivery. These 
metallic NPs ar e also considered to be nontoxic in case of gene and drug 
delivery applications. Thus, metallic NPs can offer diagnostic and thera-
peutic possibilities simultaneously [14].
The purpose of this work is to present an innovative material with high 
bactericide, fungicide and virucide efficiency in their incorporation and 
application in textile industry such as cotton-based materials that make 
special biopolymer hosts for composite materials. Finally, it is important 
to study the reliability of sintered AgNPs, to test and analyze its allergic 
response, dermatological photoirrritant and photosensitive effects, as well 
as their antimicrobial, fungicide and antiviral activity.
EXPERIMENTAL: MATERIALS AND METHODS
Application of chemical finishing onto fabrics
A fine-medium weight 67% polyester / 33% cotton woven fabric (plain 
weave, 120 g/m²; width 1,60m; ends 35/cm; picks 26/cm; yarn Ne 36 
67%Polyester / 33% cotton) purchased from local suppliers (São Carlos/SP, 
Brazil) was used for the application purpose. An AgNP colloidal solution 
(AgNP-CS) and an AgNP colloidal solution stabilized with organic poly-
mers (AgNP-OP) were applied on the polycotton fabric using pad-dry-
cure method (NanoxClean® Ag+Fresh 5K, and NanoxClean® Ag+Fresh 
Hybrid, respectively, provided by Nanox Tecnologia S.A. – São Carlos/SP - 
Brazil). An acrylic-based binder compound was used in the impregnation 
solution as well (Starcoat Denim 50GL provided by Star Colours LTDA. 
– Americana/SP, Brazil).
The polycotton fabric cut to the size of 30x30 cm was immersed in the 
solution containing 5% (% weight basis) of the antimicrobial products and 
6% of the acrylic-based binder (% weight basis), for 5 minutes and passed 
through a laboratory scale padder, with a 72% wet pick-up maintained for 
all the treatments. After drying (80°C, 3 min) the fabric was annealed at 
170°C for 3 min, then washed with deionized water and then dried at 80°C 
for 3 min in a ventilated oven. All samples were then conditioned at 25°C 
and 65% relative humidity for 48h. Samples were produced according to 
Table 1.


























Micro-Raman spectroscopy was performed using an iHR550 spectrome-
ter (Horiba Jobin-Yvon, Japan) coupled to a charge-coupled device (CCD) 
detector and an argon-ion laser (Melles Griot, United States) operating at 
λ = 514.5 nm and 200 mW. The spectra were carried out bin the range of 
100-3500 cm-1. Morphologies of the composites were analyzed by Field 
Emission Scanning Electron Microscopy (FE-SEM) on a FEI instrument 
(Model Inspect F50) operating at 1 kV. Fourier Transform Infrared Spec-
troscopy (FTIR) was performed using a Jasco FT/IR-6200 (Japan) spec-
trophotometer operated in absorbance mode at room temperature. The 
spectra were carried out in the range of 400-4000 cm-1.
Assessment of Antimicrobial Activity
The AATCC 147 Parallel Streak Standard Method(AATCC 147-2004) was 
used as a qualitative method to evaluate antibacterial activity of the treated 
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fabrics. Sterile plate count agar was dispensed in petri plates. 24 hours 
broth cultures of the test organisms (Escherichia Coli (E. coli - ATCC8739) 
and Staphylococcus aureus (S. aureus - ATCC6538) were used as inocu-
lums. Using a 10µL inoculation loop, 1 loop full of culture was loaded and 
transferred to the surface of the agar plate by making 7.5cm long parallel 
streaks 1 cm apart in the center of the plate, refilling the loop at every 
streak. The test specimen was gently pressed transversely, across the five 
inoculums of streaks to ensure intimate contact with the agar surface. The 
plates were incubated at 37°C for 18-48 hours. After incubation, a streak 
of interrupted growth underneath and along the side of the test material 
indicates antibacterial effectiveness of the fabric.
The quantitative antimicrobial activity assessment of the treated polycotton 
fabrics was determined according to AATCC Test Method 100(AATCC 
100-2004). Fabric specimens (circular swatch 4.8 cm in diameter) were 
impregnated with 1.0 mL of inoculum in a 250 mL container. The inoc-
ulum was a nutrient broth culture containing 2.0~3.0 · 105/mL colony 
forming units of microorganisms. E. coli and S. aureus were used as a 
reference for gram-negative and gram-positive bacteria, respectively, and 
C. albicans (ATCC 10231) as a reference for fungus. The microorganisms 
counted on the treated polycotton fabric and those on a controlled sample 
were determined after a 24-hour incubation period at 37°C. The antimi-
crobial activity was expressed in terms of percentage reduction of the mi-
croorganism after contact with the test specimen compared to the number 
of microbial cells surviving after contact with the control. The results are 
expressed as percent reduction of microorganisms by Eq. (1).
                               Reduction (%) = [(B-A)/B] x 100
where A and B are the numbers of bacteria or fungus recovered from the 
antimicrobial-treated and untreated polycotton fabrics in the jar incubat-
ed over the desired contact period, respectively.
Assessment of Antiviral Activity
An adaptation of ISO 18184 determination of antiviral activity of textile 
products Standard Method (ISO 18184:2019) was used as a reference 
for a quantitative method to evaluate the treated polycotton’s ability to 
inactivate the SARS-CoV-2 virus particles (SARS-CoV-2/human/BRA/
SP02cc/2020 - MT350282), under the tested conditions, at two different 
time intervals (2 and 5 minutes of contact time). The virus strain used 
in this study was previously described by [21]. The virus was inoculated 
into liquid media containing no fabric, treated or non-treated polycotton 
samples and incubated for 2 or 5 minutes. Then, they were used to infect 
cultures of Vero CCL-81 cells. After the incubation, the viral genetic ma-
terial was quantified in each condition using real-time quantitative PCR, 
and based on the control samples, the ability of each sample to inactivate 
SARS-CoV-2 was determined.
Briefly, Vero CCL-81 cells were plated onto 24-well plates at 1x105 cells 
per well. The cells were maintained in DMEM high glucose culture medi-
um (Sigma-Aldrich, 51435C) supplemented with 10% fetal bovine serum, 
100 U/mL of penicillin, and 100 µg/mL of streptomycin. The plate was 
incubated at 37 ºC, 5% CO2 atmosphere for 24 h. Following this period, 
the medium was removed and replaced with 666.7 µL of DMEM High 
Glucose/well without supplementation.
Three specimens, non-treated polycotton control and Ag-based antimi-
crobial treated polycotton samples, measuring 6.25 cm2 apiece, were test-
ed. Each tested specimen was placed into a different tube and 1.33 mL of 
DMEM high glucose medium without supplementation was added to each 
tube. In parallel, 500 µL of culture medium containing SARS-CoV-2 was 
diluted in 4.5 mL of DMEM medium without supplementation, and then 
333.4 µL of this viral suspension was added to each  tube containing the 
pieces of cloth. The mixtures were incubated with the virus for 2 min and 
the tubes were homogenized every 30 seconds. After this period, 166.7 µL 
of each sample was transferred to different wells of the plates containing 
the cells previously seeded. After a total of 5 min of incubation, an addi-
tional 166.7 µL of the same aliquot was removed from each tube and incu-
bated in other wells on the same plate. As control, the viral suspension was 
incubated in media without supplementation and no cloth, with samples 
collected at 2 and 5 min used to infect Vero cells on the same plate
The plate was incubated for 2 h at 37 ºC, 5% CO2 for viral adsorption, and 
after this period, 166.6 µL of DMEM High Glucose medium containing 
12% fetal bovine serum were added to each well, making to a final volume 
of 1 mL of medium/well containing 2% serum. Immediately after add-
ing the medium, the plate was further incubated at 37 ºC, 5% CO2. After 
48 h, the plate was removed from the incubator and 100 µL of the medi-
um from each well (each well containing a different condition) was re-
moved and placed in lysis buffer to proceed with the viral RNA extraction. 
For the extraction, the MagMAX™ CORE Nucleic Acid Purification Kit 
(Thermo Fisher) was used, following the manufacturer’s instructions, on 
the semi-automated platform MagMAX Express-96 (Applied Biosyste-
ms, Weiterstadt, Germany). The detection of viral RNA was carried out 
using the AgPath-ID One-Step RT-PCR Kit (Applied Biosystems) on an 
ABI 7500 SDS real-time PCR machine (Applied Biosystems), using a pub-
lished protocol and sequence of primers and probe for E gene [22]. The 
number of RNA copies/mL was quantified by real-time RT-qPCR using a 
specific in vitro-transcribed RNA quantification standard, kindly granted 
by Christian Drosten, Charité - Universitätsmedizin Berlin, Germany, as 
described previously [23]. The viricidal activity, or viral inactivation, was 
determined as a percentage related to the control (media without fabric 
specimen).
The experiment was repeated using the same experimental conditions, but 
with media incubated with two pieces of test specimens (instead of one) 
per condition.
Assessment of Allergic Response
A Human Repeat Insult Patch Test (HRIPT) was performed to determine 
the absence of the potential for dermal irritability and sensitization of 
the treated fabrics. The study was carried out in maximized conditions, 
in which semi-occlusive dressings containing the investigational product 
and controls were applied to the participants’ backs. The application of 
the study dressings occurred for six weeks, with three weeks of applica-
tion alternately, two weeks of rest and a new application of the dressing 
containing the product in virgin area in the sixth week (challenge). The 
readings of the application site were performed at each dressing change 
according to the reading scale recommended by the International Contact 
Dermatitis Research Group (ICDRG) [24]. Dermatological evaluations 
were carried out at the beginning and end of the study, and a physician 
was available for evaluation and assistance to the participants in case of 
positive or adverse reaction. Participants of both genders, with phototypes 
III to IV [25], aged between 21 and 70 were selected. The selected partici-
pants were distributed as shown in the Table 2.
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Assessment of Dermatological Photoirrritant and Photo-
sensitive Potential
Since exposure to solar radiation can trigger or aggravate adverse reac-
tions to topical products, knowing the behavior of the product on human 
skin stimulated with ultraviolet radiation is of fundamental importance 
for proof of safety. Therefore, a unicentric, blind, comparative clinical 
study to assess the photoirritating and photosensitizing potential was also 
conducted, with the aim of proving the absence of the irritating potential 
of the product applied to the skin when exposed to ultraviolet radiation. 
The study was carried out with dressings containing the product, applied 
to the participants’ skin and, after removal, controlled irradiation with a 
spectrum of ultraviolet radiation emission was performed. Readings were 
performed according to the reading scale recommended by the ICDRG. 
The study with the participants lasted for five weeks, covering 3 phases: 
induction, rest and challenge. Dermatological evaluations were performed 
at the beginning and end of the study, or when there was an indication of 
positivity or adverse reaction. Participants of both genders, with photo-
type III [25], aged between 21 and 62 were selected. The selected partici-
pants were distributed as shown in the Table 3.
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RESULTS AND DISCUSSION
There are numerous ways to functionalize a textile substrate, from devel-
opment of new structures until finishes that modify the material surface. 
The superficial modification through the incorporation of nanoparticles 
has been extensively studied and shows promise for obtaining devices with 
microbicidal activity [26-31]. In this scenario, nanoparticles can advanta-
geously replace micrometric particles used in the finishes to obtain func-
tional fabrics, because it has a greater surface area, resulting in a better 
adhesion to fabrics and, thus, greater durability of functionality. Further-
more, it is possible to achieve a pronounced effect with small amounts of 
material without changing the original properties of the fabric. Tradition-
ally, the pad-dry-cure is most common finishing route applied to impart 
different finish treatments on textile fabrics [32, 33]. In this way, the in-
teractions between the tissue and the Ag NPs were investigated, in order 
to observe how these changes mirrored the microbicidal properties in the 
new Ag-based fabric.
In order to analyze the local structural order/disorder caused by the ad-
dition of Ag-based antimicrobials to polycotton, micro-Raman analyzes 
were performed. The results are presented in Figure 1. The adhesion and 
durability of a superficial change in fabrics depends on the surface chem-
ical properties [26]. Since the main component of polycotton is cotton 
(formed by glucose monomers) and polyester (polyethylene terephthal-
ate), the vibrations refer to C, O and H bonds. The cotton Raman spectra 
of the samples can be divided into four blocks related to the glycosidic 
ring skeleton, to OH groups, the CH and CH2 groups, and acetylation of 
cotton. The glycosidic ring presents the fingerprint of the cotton Raman 
spectra. These modes can be observed at 859, 1104, 1123 and 1183 cm-1 
and represent the symmetrical stretching of C-O-C in the plane, asymmet-
ric and symmetrical stretching of C-O-C in the glycosidic link, and asym-
metric stretching of C-C ring breathing [34]. The presence of OH groups 
in the samples is observed by the modes located at 287 and 1464 cm-1, 
related to the twisting and deformation of the C-OH bonds [35, 36]. Four 
modes related to CH2 deformations and twisting are observed in 1000, 
1291, 1372 and 1418 cm-1. There is still a mode located at 289 cm-1 regard-
ing the twisting of the C-CH bond [37]. The acetylation of the cotton used 
is further confirmed by the modes located at 705 and 795 cm-1, referring 
to deformation O-C=O and the stretching of the H3C-C bonds [38]. Like 
cotton, polyester has its fingerprint given by the modes referring to its ar-
omatic ring and its esters. It is observed in 1613 cm-1 the mode referring 
to the stretching of the C1-C4 carbon of the aromatic polyester ring, as well 
as its CH stretching in 3078 cm-1 [39]. It is also possible to observe in 1730 
cm-1 the stretching of the C=O bonds of the esters and the stretching of the 
CH bonds of the methyl groups external to the ring, in 2975 cm-1[39,40]. 
It is observed that the addition of Ag-based antimicrobials do not cause 
significant changes in the polycotton structure at short-range.
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As a complementary analysis to micro Raman spectroscopy, FTIR mea-
surements were performed to investigate the functional groups of prod-
ucts after the incorporation of the two Ag-based antimicrobial solutions 
into the polycotton (Figure 2). It is observed in the samples of pure poly-
cotton and those modified with the Ag-based antimicrobials the peaks lo-
cated at 3540, 2936, 2124, 1947, 1710, 1338, 1147, 832 and 647 cm-1. The 
peaks located at 3540, 2936 and 2124 cm-1 refer to OH stretching and 
CH deformation respectively, the latter being related to the CH2 groups 
of the cellulose structure [41, 42]. The peaks located in 1947, 1710, 1338 
and 1147 cm-1 correspond respectively to H2O adsorbed on the polycotton 
surface, stretching of the CH bond, asymmetric deformation of the C-O-C 
groups and were attributed to stretching vibrations of intermolecular ester 
bonding [42-44]. As in the Raman spectra, the cotton fingerprint can be 
observed in the FTIR due to the presence of the band located at 832 cm-1, 
referring to the asymmetric stretching of the glycosidic ring, especially the 
C1-O-C4 bonds [43]. It is observed for the modified polycotton in rela-
tion to the non-treated polycotton the displacement of the band located 
at 1338 cm-1, as well as the decrease of the band located around 647 cm-1, 
referent to in-plane bending of O-H mode from the glycosidic units and 
deformation of the OH, respectively[45, 46]. These shifts, as well as the 
appearance of new bands in the FTIR spectra of the modified polycotton 
are due to interactions between polycotton and Ag-based antimicrobial 
additives [47-49].
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                          Figure 1. Micro Raman spectra of (a) Non-Treated Polycotton, (b) Polycotton AgNP-CS and (c) Polycotton AgNP-OP
                                  
                                                      
                                                     Figure 2. FTIR spectra of (a) Non-Treated Polycotton, (b) Polycotton AgNP-CS and (c) Sample 2
To observe morphological changes in polycotton fibers, FE-SEM mea-
surements were performed (Figure 3). There are no significant differences 
in the fiber diameters of the samples, being the average diameter values 
obtained for the Non-Treated Polycotton, Polycotton AgNP-CS and Poly-
cotton AgNP-OP were 10.62 ± 2.30, 10.22 ± 2.04 and 10.59 ± 2.50 μm 
respectively.  For Polycotton AgNP-CS (Figures 3d-f), it is possible to ob-
serve the formation of small Ag nanoparticles on the polycotton surface, 
with average size of the 23.51 ± 5.18 nm. Similar behavior was obtained 
by several other authors in works that incorporated AgNPs into polycot-
ton in different ways [50-57]. For Polycotton AgNP-OP, the formation of a 
smaller amount of Ag nanoparticles with average size higher (126.9 ± 19.5 
nm) than the than Polycotton AgNP-CS were observed. In addition, there 
is a homogeneous distribution of micrometric crystals with well-defined 
morphology over all polycotton surface fibers, with an average size of 1.62 
± 0.44 μm. These differences are due to the different composition of both 
Ag-based antimicrobials, which result in different surface effects on poly-
cotton surface fibers.
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                                  Figure 3. FE-SEM images of (a-c) Non-Treated Polycotton, (d-f) Polycotton AgNP-CS and (g-i) Polycotton AgNP-OP                       
Since Ag-based antimicrobial additives caused distinct surface interac-
tions in polycotton fibers, it is expected that this difference will be reflected 
in their physical, chemical and biological properties. In this sense, experi-
ments were carried out to evaluate the biological properties of composites 
obtained through the allergenic response to humans and microbicidal ac-
tivity against E. coli, S. aureus, C. albicans and SARS-CoV-2.
The AATCC 147 test results against S. aureus (gram positive) and E. coli 
(gram negative) bacteria for the non-treated and the Ag-based antimicro-
bial treated polycotton samples are shown in Figure 4 and Table 4. For the 
control polycotton, growth of E. coli and S. aureus was observed under 
the specimen while no growth appeared for the treated fabric. The zone 
of inhibition for the control sample was 0 mm, in comparison to 2-3 mm 
for the treated fabric. It can be seen from these results that the Ag-based 
antimicrobials treated fabrics displayed a high level of antibacterial per-
formance.
The antibacterial mechanism for gram-positive and gram-negative bacte-
ria is associated with Ag NPs and their penetration into the cell membrane 
of these microorganisms. Ag NPs are able to penetrate cell membranes and 
release Ag+ ions, which have a high affinity to react with phosphorus and 
sulfur compounds, either from the membrane or from inside the cell [58]. 
In addition, Ag NPs can generate reactive oxygen species (ROS), which 
cause an accumulation of intracellular ROS, leading to bacterial death 
from oxidative stress [59].
Table 4: AATCC 147 tests results against S. aureus and E. coli for non-treated 
(control) and Ag-based antimicrobials treated fabric samples.
Antimicrobial Prod-
uct 
E. coli S. aureus




Polycotton AgNP-CS No No
Polycotton AgNP-OP No No




Polycotton AgNP-CS 3 2.5
Polycotton AgNP-OP 2 2
The halo inhibition test (AATCC 147) is only a qualitative test that shows 
bacterial inhibition, requiring a qualitative test to determine the percent-
ages of inhibition (AATCC 100). The quantitative antimicrobial activities 
of finished textiles treated with the two different Ag-based antimicrobials 
according to the AATCC 100 standard are shown in Table 4. These tests 
were also performed with C. albicans, in order to assess the fungicidal 
potential of the Ag-based fabrics. In agreement with the qualitative test, 
the quantitative test showed that in all the Ag-based treated polycotton 
samples had efficient antimicrobial activities, against bacteria and fungi, 
displaying a 99.99% reduction in all tested samples.
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Figure 4. AATCC 147 test result against E. coli for the Non-Treated Polycotton sample as a reference (a) and for the Ag-based antimicrobial treated 
polycotton (b – Polycotton AgNP-CS and c – Polycotton AgNP-OP) and AATCC 147 test result against S. aureus for the Non-Treated Polycotton sample 
as a reference (d) and for the Ag-based antimicrobial treated fabric (e –Polycotton AgNP-CS and f – Polycotton AgNP-OP) exhibiting, respectively, no 
peripheral inhibition and a measurable zone of inhibition.
The antiviral activity test was designed to determine the inactivation of 
viral particles upon short exposure to the products, which in this case were 
the Ag-based treated polycotton samples incubated in liquid media. After 
a short period of incubation, the media were transferred to a cell culture, 
where viable virions would be able to enter cells and replicate within. The 
supernatant of cell cultures was recovered after 48 h and the viral load 
was determined by RT-qPCR, resulting in the determination of number of 
viral RNA copies per mL.
Table 6 shows the number of copies of the control media without any fab-
ric sample, non-treated polycotton, and the two Ag-based treated poly-
cotton samples at the two different tested time periods. With the result of 
the number of copies of each sample, the viral inactivation effect of each 
cloth was calculated, using the media without any fabric sample as control.

















1.55 X 109 16.57%
Polycotton 
AgNP-CS
2.48 X 108 86.65%
Polycotton 
AgNP-OP












2.14 X 108 83.12%
Polycotton 
AgNP-OP
5.50 X 107 95.65%
Regarding the second experiment, the number of copies per milliliter in 
each sample was also obtained and the percentage of inhibition of the 
products was calculated from the control media without any fabric sample. 
The obtained results were summarized in Table 7.

















3.27 X 109 21.28%
Polycotton 
AgNP-CS
6.82 X 108 83.57%
Polycotton 
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2.34 X 109 22.77%
Polycotton 
AgNP-CS
3.60 X 108 88.12%
Polycotton 
AgNP-OP
1.04 X 105 99.99%
The following graphs represent the data described in Tables 5 and 6, of the 
control media without any fabric sample, non-treated polycotton, and the 
two Ag-based treated polycotton samples.
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2.1 x 105 2.2 x 105 - 2.3 x 105 2.2 x 105 - 2.0 x 105 2.2 x 105 -
Polycotton 
AgNP-CS
2.1 x 105 1.6 x 10 99.99% 2.3 x 105 1.3 x 10 99.99% 2.0 x 105 1.3 x 10 99.99%
Polycotton 
AgNP-OP
2.1 x 105 1.1 x 10 99.99% 2.3 x 105 1.1 x 10 99.99% 2.0 x 105 1.4 x 10 99.99%
                                           aPercent bacterial reduction as measured against a non-treated control.
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Figures 5 and 6 show the results of the first and second experiments, respectively, indicating the number of viral copies per mL and the percentage of 
inhibition of each compound above the bar referring to it. Inhibition was calculated for each treatment using its respective control.
                                        
                                     Figure 5. Representative graph of the data obtained in the first experiment, relating the tested products to the viral load found 
and the percentage of inhibition.
                                              Figure 6. Representative graph of the data obtained in the second experiment, relating the tested products to the viral load 
found and the percentage of inhibition.
In both experiments, in the two time periods tested, the untreated polycot-
ton showed a subtle activity, which was already expected by data already 
published by Chin and colleagues[60]. Polycotton AgNP-CS showed a 
high viricidal activity when incubated with the virus. At both time periods 
in both experiments, Polycotton AgNP-OP obtained a higher rate of viral 
inactivation compared to Polycotton AgNP-CS.
In short, both treated polycotton samples were effective in viral inhibi-
tion in 2 and 5 minutes in two different experiments, where there was 
variation in the amount of virus per cm² of fabric (4x less virus/cm² in 
the second experiment). Polycotton AgNP-OP showed the best activity, 
reaching 99.99% within two minutes of incubation with the virus in the 
second experiment. Polycotton AgNP-CS, despite being less effective than 
Polycotton AgNP-OP, showed high anti-SARS-CoV-2 activity, with more 
than 80% inhibition rate in all tests performed.
As an antiviral agent, Ag NPs can interfere with viral replication by two 
separate mechanisms of adhesion to the surface of the viral envelope. 
This adhesion prevents the virus from being able to bind to the hostcell, 
preventing contamination and possible damage [61, 62]. These antiviral 
mechanisms are mainly caused by stress in infected cells (due to phys-
ical contact), generation of reactive oxygen species (ROS), interactions 
with DNA and enzymatic damage [63]. The first mechanism is through 
the binding of Ag NPs with sulfur residues from the virus’s surface gly-
coproteins, preventing interaction with the receptor and its entry into the 
host cell [64, 65]. The second mechanism involves the passage of Ag NPs 
through the cell membrane that consequently, it ends up effectively block-
ing the transcription factors necessary for the adequate assembly of the 
viral progeny [66]. Thus, in addition to the unique behavior of Ag NPs in 
isolation, its interface with polymers can be explored, which may open the 
way for new ones promising applications in several fields of action.
Both the Human Repeat Insult Patch Test and the clinical study to assess 
the photoirritating and photosensitizing potential were conducted accord-
ing to the Cosmetic Product Safety Assessment Guide, published by the 
Brazilian regulatory agency ANVISA [67], by the ECOLYZER Group (São 
Paulo/SP, Brazil), an independent and ISO certified laboratory. For the 
HRIPT, Primary Dermal Irritability, Accumulated Dermal Irritability and 
Dermal Sensitization potential were determined. The clinical evaluation 
criterion was the observation of clinical signs or symptoms such as swell-
ing (edema), redness (erythema), papules and vesicles according to the 
reading scale recommended by the ICDRG. No adverse reactions (erythe-
ma, edema, papules or vesicles) were detected in the product’s application 
areas, in the analysis of primary and accumulated irritability, sensitization, 
during the study period. The same clinical evaluation criterion was used 
to determine the Dermal Photoirritation and Dermal Photosensitization 
in the clinical study. As in the HRIPT, on this study no adverse reactions 
(erythema, edema, papules or vesicles) were detected in the product’s ap-
plication areas during the study period. According to the results obtained 
from the sample of participants studied, we can conclude that the treated 
fabrics did not induce a photoirritating, photosensitizing, irritation nor 
sensitization process and, therefore, can be considered hypoallergenic and 
dermatologically tested and approved, being considered safe, according to 
ANVISA’s Guide for Cosmetic Product Safety.
CONCLUSIONS
Infections, contaminations, and biofouling resulting from micro- and/
or macro-organisms remained a prominent threat to the public health, 
food industry, and aqua-/marine-related applications. Considering envi-
ronmental and drug resistance concerns as well as insufficient efficacy on 
biofilms associated with conventional disinfecting reagents, developing an 
antimicrobial surface potentially improved antimicrobial performance by 
directly working on the microbes surrounding the surface area. 
Here we provide an engineering perspective on the logic of choosing mate-
rials and strategies for designing antimicrobial surfaces and their potential 
impacts in order to improve our current and future economical, social and 
environmental system. In this present study, we have developed a polycot-
ton fiber, Ag-based material, using pad-dry-cure method. Upon contact, 
this coating shows antimicrobial activity against S. aureus, E. Coli, C. al-
bicans and SARS-CoV-2., inhibitind nearly Futhermore, of the material 
was alble toinfection, do not cause allergies or photoirritation, proving the 
safety of its use, that could effectively address the antimicrobial require-
ment for a variety of applications, and some of them have already been 
implemented as commercial products. 
The differential capabilities of this Ag-based fabrics are their universality 
and prevention of cross infection caused by pathogens, such as opportu-
nistic bacteria and fungi, responsible for the worsening of COVID-19 and 
other types of viruses on different surface materials. The fabrication of 
these materials may provide new insights into the development of protec-
tion materials in a sustainable, self-recharging, and structurally adaptive 
form.
Our results address the concerns of cytotoxicity in the application of 
Ag-containing materials toward the development of bioapplications in 
the fields of health and environment. Based on the significant ongoing 
research, it is expected that these new materials play an outstanding role 
not only in this type of products but also in other important areas such as 
tissue engineering, photodynamic therapy, catalytic processes, biosensors, 
bioactuators, medical therapy equipment, and smart wearable devices. It is 
believed that future research on antimicrobial surfaces would benefit from 
a comprehensive understanding of fundamentals, e.g., working mecha-
nisms for potential materials/strategies and challenges/requirements from 
an application perspective.
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